Skip to main navigation

About Us

Our Company

Overview Management Team Board of Directors Scientific Advisory Board Partners & Collaborations

Contact

Our Pipeline

Pipeline

Overview Azenosertib ZN-d5 BCL-xL Degrader

Clinical Trials

Our Approach

Integrated Discovery Engine

Our advanced approach to efficiently identifying and developing novel oncology therapies.

Supporting Publications

Investors & Media

Investor Home

News & Events

Press Releases Events & Presentations

Stock Information

Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage

Financials & Filings

SEC Filings

Corporate Governance

Documents & Charters Management Team Board of Directors Scientific Advisory Committee Committee Composition

Investor Resources

Investor FAQs Investor Contact Email Alerts

Careers

Working at Zentalis

Be part of a vibrant team committed to our common goal: to better the lives of patients impacted by cancer.

Job Opportunities

Investors & Media

Biography

Investor Relations Menu

Investor Home

News & Events

Press Releases Events & Presentations

Stock Information

Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage

Financials & Filings

SEC Filings

Corporate Governance

Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition

Investor Resources

Investor FAQs Investor Contact Email Alerts

Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Emily White
Solebury Strategic Communications
ewhite@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

Diana Hausman, MD

Board Member

Member of the Compensation Committee
Member of the Nominating and Corporate Governance Committee

Corporate Office

1359 Broadway
Suite 801
New York, NY 10018

Science Center

10275 Science Center Drive
Suite 200
San Diego, CA 92121

About Us

Our Company Management Team Board of Directors Scientific Advisory Board Partners & Collaborations Contact

Our Pipeline

Overview Azenosertib ZN-d5 BCL-xL Degrader Clinical Trials

Our Approach

Integrated Discovery Engine Supporting Publications

Investors & Media

News & Events Stock Information Financials & Filings Corporate Governance Investor Resources

Expanded Access Policy

Site Map

Careers